Analyst Recommendations

Piper Sandler analyst issues NEUTRAL recommendation for ADBE on February 2, 2026 09:13PM ET. The previous analyst recommendation was Overweight.ADBE was trading at $293.38 at issue of the...

February 2, 2026   ADBE 0.83%

Piper Sandler analyst issues OVERWEIGHT recommendation for CRM on February 2, 2026 09:17PM ET. The previous analyst recommendation was Overweight.CRM was trading at $210.81 at issue of the...

February 2, 2026   CRM 0.90%

Cowen & Co. analyst issues HOLD recommendation for CVX on February 2, 2026 01:57PM ET. The previous analyst recommendation was Hold.CVX was trading at $173.495 at issue of...

February 2, 2026   CVX -2.03%

UBS analyst issues BUY recommendation for CVX on February 2, 2026 01:58PM ET. The previous analyst recommendation was Buy.CVX was trading at $174.2 at issue of the analyst...

February 2, 2026   CVX -2.03%

UBS analyst issues NEUTRAL recommendation for VZ on February 2, 2026 02:04PM ET. The previous analyst recommendation was Neutral.VZ was trading at $44.08 at issue of the analyst...

February 2, 2026   VZ -0.22%

RBC Capital analyst issues SECTOR PERFORM recommendation for AMD on February 2, 2026 02:27PM ET. The previous analyst recommendation was Sector Perform.AMD was trading at $244.98 at issue...

February 2, 2026   AMD 3.78%

Cowen & Co. analyst issues BUY recommendation for VZ on February 2, 2026 02:06PM ET. The previous analyst recommendation was Buy.VZ was trading at $44.085 at issue of...

February 2, 2026   VZ -0.22%

RBC Capital analyst issues SECTOR PERFORM recommendation for XOM on February 2, 2026 01:44PM ET. The previous analyst recommendation was Sector Perform.XOM was trading at $141.63 at issue...

February 2, 2026   XOM -1.19%

BMO Capital analyst issues OUTPERFORM recommendation for CVX on February 2, 2026 12:25PM ET. The previous analyst recommendation was Outperform.CVX was trading at $177.01 at issue of the...

February 2, 2026   CVX -2.03%

UBS analyst issues BUY recommendation for XOM on February 2, 2026 11:36AM ET. The previous analyst recommendation was Buy.XOM was trading at $141.63 at issue of the analyst...

February 2, 2026   XOM -1.19%